NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT02080416 2016-06-10Nelfinavir for the Treatment of Gammaherpesvirus-Related TumorsSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase EARLY_PHASE1 Terminated1 enrolled